Drug-Induced QT Prolongation

On this page

QT Interval & TdP - Electric Heartbeat Hiccups

  • QT Interval: ECG: Start of QRS to end of T wave. Represents ventricular repolarization; duration varies with heart rate.
  • Corrected QT (QTc): Adjusts QT for heart rate.
    • Bazett's Formula: $QTc = QT / \sqrt{RR}$.
    • Prolonged QTc thresholds (risk of TdP):
      • Men: > 450ms
      • Women: > 470ms
    • Very High Risk for TdP: QTc > 500ms.
  • Torsades de Pointes (TdP):
    • Life-threatening polymorphic ventricular tachycardia.
    • Triggered by QT prolongation.
    • ECG: 'Twisting of points' appearance.

    ⭐ Torsades de Pointes (TdP) is a polymorphic ventricular tachycardia specifically associated with QT prolongation, appearing as a 'twisting of points' on ECG. ECG: Long QT interval and Torsades de Pointes

Causative Drugs - Pharma's QT Stretchers

Many drugs prolong QT, risking Torsades de Pointes (TdP). Key classes:

Drug ClassExamples
AntiarrhythmicsClass IA (Quinidine, Procainamide, Disopyramide), Class III (Amiodarone, Sotalol, Dofetilide, Ibutilide)
AntibioticsMacrolides (Erythromycin, Clarithromycin, Azithromycin), Fluoroquinolones (Ciprofloxacin, Levofloxacin, Moxifloxacin)
AntipsychoticsHaloperidol, Thioridazine, Ziprasidone, Risperidone, Olanzapine
AntidepressantsTCAs (Amitriptyline, Imipramine), SSRIs (Citalopram, Escitalopram)
AntiemeticsOndansetron, Domperidone, Droperidol
AntifungalsAzoles (Fluconazole, Ketoconazole, Itraconazole)
OthersMethadone, Chloroquine, Hydroxychloroquine, Cisapride, Sumatriptan
  • Antiarrhythmics (Class IA, III)
  • AntiBiotics (Macrolides, Quinolones)
  • AntiCychotics (e.g., Haloperidol)
  • AntiDepressants (TCAs, SSRIs)
  • AntiEmetics (e.g., Ondansetron)

⭐ Many non-antiarrhythmic drugs, such as macrolide antibiotics (e.g., erythromycin), fluoroquinolones, antipsychotics (e.g., haloperidol), and ondansetron, are notorious for causing QT prolongation.

Risk Factors - Dodging Danger Zones

  • Patient-Specific Vulnerabilities:
    • Female gender, advanced age (>65 yrs)
    • Genetic predisposition (e.g., congenital LQTS variants)
    • Underlying structural heart disease (e.g., MI, HF, LVH)
    • Baseline bradycardia or AV block
  • Modifiable/External Factors:
    • Polypharmacy: multiple QT-prolonging agents
    • Drug interactions (e.g., CYP3A4 inhibitors)
    • Rapid IV administration of offending drugs
    • Renal or hepatic impairment (↓ drug clearance)

    ⭐ Electrolyte abnormalities, particularly hypokalemia and hypomagnesemia, are major predisposing factors that significantly potentiate drug-induced QT prolongation and risk of TdP.

Clinical Picture & Management - Taming Torsades Twists

ECG: QT prolongation to Torsades de Pointes

  • Presentation: Often asymptomatic. Palpitations, dizziness, syncope; can lead to Sudden Cardiac Death (SCD).
  • ECG: QTc >450ms (males), >470ms (females); >500ms = high risk. Torsades de Pointes (TdP): characteristic polymorphic VT, "twisting of points".
  • Management Algorithm:

⭐ Intravenous Magnesium Sulfate is the first-line treatment for Torsades de Pointes, even in patients with normal serum magnesium levels.

  • Key Interventions: Discontinue culprit agent. Aggressively replete K⁺ (target 4.5-5.0 mEq/L) and Mg²⁺. Monitor ECG continuously during acute phase.
  • QT prolongation indicates delayed ventricular repolarization, risking Torsades de Pointes (TdP).
  • Critical risk factors: female sex, hypokalemia, hypomagnesemia, bradycardia, structural heart disease.
  • Common drug classes: Antiarrhythmics (IA, III), antipsychotics, macrolides, fluoroquinolones, azole antifungals, ondansetron.
  • Main mechanism: Blockade of the IKr (hERG) potassium channel.
  • TdP treatment: Discontinue drug, correct electrolytes (K+, Mg2+), IV magnesium sulfate.
  • QTc monitoring is crucial; Bazett's formula (QTc = QT/√RR) is often used.

Practice Questions: Drug-Induced QT Prolongation

Test your understanding with these related questions

Identify the ECG given below?

1 of 5

Flashcards: Drug-Induced QT Prolongation

1/10

Type _____ adverse drug reactions are based on the pharmacological properties of the drug

TAP TO REVEAL ANSWER

Type _____ adverse drug reactions are based on the pharmacological properties of the drug

A (augmented)

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial